Showing all 3 results
Ramipril and Amlodipine Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended Capsule or Film-Coated Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu blister strips to ensure the absolute chemical stability of the highly degradable Ramipril molecule.
Active Ingredient Strength Primary Clinical Function Ramipril Ph.Eur./USP 5 mg / 10 mg ACE inhibition for vasodilation, neurohormonal blockade, and venous pressure equalization. Amlodipine (as Besilate) Ph.Eur./USP 5 mg / 10 mg Global Clinical Standard: Sustained CCB for profound, 24-hour arterial vasodilation. Excipients Microcrystalline Cellulose / Crospovidone / Sodium Stearyl Fumarate / Hypromellose / Iron Oxide Red Diluent / Superdisintegrant / Alkaline Stabilizing Lubricant (Engineered to protect Ramipril from acidic degradation and moisture) *Pack Sizes: 10×10 Alu-Alu Blisters or 3×10 Unit-Dose Blisters (Optimized specifically for strict, high-compliance 30-day chronic cardiology dispensing regimens).
Telmisartan & Atorvastatin Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Engineered Bilayer Film-Coated Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu blister strips to ensure the absolute stability of both the hygroscopic ARB and the sensitive Statin.
Active Ingredient Strength Primary Clinical Function Telmisartan USP/Ph.Eur. 40 mg Standard ARB maintenance dose for continuous 24-hour peripheral vasodilation and RAAS blockade. Atorvastatin Calcium USP/Ph.Eur. 10 mg (Equivalent to Atorvastatin base) Standard initiation and maintenance dose for moderate-intensity LDL cholesterol reduction. Excipients Meglumine / Calcium Carbonate / Microcrystalline Cellulose / Magnesium Stearate Alkalizer for Telmisartan / Micro-environment stabilizer for Atorvastatin (Engineered for kinetic segregation) Telmisartan Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended Uncoated Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu blister strips. The formulation utilizes specialized alkalizing agents to ensure the highly insoluble API rapidly dissolves in the gastrointestinal tract.
Active Ingredient Strength Primary Clinical Use Telmisartan USP/BP/Ph.Eur. 20 mg Initiation / Hepatic Impairment: Low-dose titration for sensitive or hepatically compromised patients. Telmisartan USP/BP/Ph.Eur. 40 mg Standard Global Dose: Once-daily maintenance therapy for essential hypertension. Telmisartan USP/BP/Ph.Eur. 80 mg Maximum CV Protection: High-dose therapy for severe hypertension and mandated cardiovascular risk reduction. Excipients Meglumine / Sodium Hydroxide / Povidone / Magnesium Stearate Alkalizing Stabilizer / Binder / Lubricant (Engineered to prevent API crystallization and ensure rapid absorption)
